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Abstract
Membrane proteins are mostly protein– lipid complexes. For more than 30 examples of membrane proteins from prokaryotes, yeast, plant
and mammals, the importance of phospolipids and sterols for optimal activity is documented. All crystallized membrane protein complexes
show defined lipid–protein contacts. In addition, lipid requirements may also be transitory and necessary only for correct folding and
intercellular transport. With respect to specific lipid requirements of membrane proteins, the phospholipid and glycolipid as well as the sterol
content of the host cell chosen for heterologous expression should be carefully considered. The lipid composition of bacteria, archaea, yeasts,
insects, Xenopus oocytes, and typical plant and mammalian cells are given in this review. A few examples of heterologous expression of
membrane proteins, where problems of speific lipid requirements have been noticed or should be thought of, have been chosen.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Biological membranes in general consist of various phos-
pho- and glycolipids and sterols, which amount to approx-
imately 50% by mass, the other half being constituted by
membrane proteins. Major deviations from this general lipid
composition are found in the archaea, which contain ether
lipids with phytanyl residues instead of ester-linked fatty
acids, and in all prokaryotes which lack sterols altogether. An
important open question has long been, whether membrane
proteins are associated with specific lipids and whether they
are dependent on these for structural integrity and function.
Considerable evidence confirming that this is indeed the case
has been published within the last few years. The idea that
membrane proteins in reality are protein–lipid complexes
has been commonly accepted. The old puzzle, namely, why
are there so many lipid species, although very few would
suffice to account for the barrier function of membranes, may
at least in part be related to the specific requirement of fitting
partners for membrane proteins.
It is evident that membrane proteins do require specific
lipids, be it as cofactors for their functions or as ‘‘co-
structures’’ for their correct folding and stability. This
should be taken into account when one attempts to perform
heterologous expression of a membrane protein. The
requirement for specific lipids may pose problems, even if
one uses the right promoters and terminators, the correct
targeting signals and posttranslational processing.
In this review, we first present conclusive examples
showing that membrane proteins and membrane protein
complexes do depend on phospholipids and sterols for their
integrity and activity. For the sake of brevity, we did not
include bulk effects of lipid composition on the physical
properties of membranes, although they definitely do affect
membrane proteins. We tried to collect the available data
concerning the lipid composition of various organisms,
concentrating on those most frequently used for heterolo-
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gous expression. Finally, we briefly discuss a few cases of
heterologous expression of membrane proteins.
2. Effect of phospholipids and sterols on activities of
membrane proteins
Evidence establishing functions of lipids in membrane
processes derived from studies of in vitro systems is based
predominantly on analysis of kinetic parameters of substrate
binding and/or ATP hydrolysis performed by a protein either
in its native membrane or in an artificial lipid bilayer.
Reconstitution of a purified membrane protein into sealed
proteoliposomes of a defined composition has made it
possible to assess the effects of lipids also on processes of
vectorial transport. This approach includes protein solubili-
zation and purification employing various detergents. The
choice of a detergent and purification conditions determines,
to a large degree, the membrane protein activity after its
reconstitution. Complete membrane protein delipidation
usually leads to protein inactivation, which, however, in
some instances can be reversed by readdition of external
lipids. The selectivity for the lipids that are able to restore
the activity of the membrane protein represents another tool
for studies of specific lipid requirements [1].
To understand the real situation in a living cell, the in
vitro observations need to be validated by in vivo
approaches. For this purpose, a genetic approach of disrupt-
ing a pathway responsible for the synthesis of a specific
phospholipid has been widely employed. Utilizing a set of
mutations in the phospholipid metabolism in Escherichia
coli and Saccharomyces cerevisiae, it has recently been
possible both to validate the knowledge from in vitro
experiments and to uncover novel previously undocumented
functions of phospholipids (for E. coli review, see Ref. [2]).
In Table 1, examples of membrane proteins affected by
specific lipids have been collected.
Among membrane proteins of mammalian cells, the
multidrug resistance P-glycoprotein (Pgp) and the Ca2 +
ATPase from sarcoplasmic reticulum are two proteins for
which the effects of lipid environment have been intensively
studied. Specific stimulatory and/or inhibitory effects on
drug binding affinity and/or ATPase activity were reported
for Pgp. However, a comprehensive study of Romsicki and
Sharom [49] points to a modulation of the drug expulsion
from cells by the lipid environment immediately adjacent to
the transporter. Both the nature of the head group and the
acyl chain composition as well as the state of lipid phase
modulate Pgp activity. Binding affinity differs for different
drugs. The ATPase activity was found to correlate with drug
partitioning into the lipid phase of the membrane [49].
Direct and indirect influence of cholesterol on membrane
protein function has been documented for a number of
membrane receptors. Mild techniques of a reversible cho-
lesterol depletion or its modification in membranes [13]
accompanied by monitoring the membrane fluidity [14]
distinguished two mechanisms how cholesterol affects the
ligand binding function, either by changing membrane
fluidity and/or by a specific cholesterol–receptor interac-
tions [14,15]. Highly specific molecular interactions result
either in the receptor stabilization until it reaches its place of
function (e.g. rhodopsin—Ref. [50]) or stabilization of the
receptor in a high-affinity state. Some of the receptors
exhibit a very stringent and unique requirement for the
exact sterol structure [10].
A large number of mitochondrial proteins interact with
cardiolipin (CL) which was found to be strongly immobi-
lized on the protein surface. Dissociation of CL from the
ADP/ATP carrier can only be achieved under denaturing
conditions [22]. On the other hand, the loss of tightly bound
CL from cytochrome c oxidase does not lead to its complete
inactivation [20]. More examples documenting the signifi-
cance of CL in mitochondrial processes and its involvement
in human diseases have recently been reviewed [19].
The role of phosphatidyl glycerol (PG) and CL in
bacterial membranes and in mitochondria is fundamental;
however, in some cases, it appeared that they can substitute
for one another in certain essential biological functions [51].
Negatively charged lipids such as PG and CL appear to be
indispensable for membrane insertion and protein trans-
location via the translocase [32,33], and for membrane
targeting [52]. A specific function of CL was postulated in
the formation of a pore in connection with hyaluronan
synthase from Streptococcus [34].
In yeast, a general requirement for CL of the ATP/ADP
carrier in mitochondrial membrane was unmasked in a
mutant affected in CL binding. The addition of an excess
of CL to the in vitro system restored nucleotide translocation
by the mutated protein [23]. Reconstitution experiments
with the Can1p permease from S. cerevisiae incorporated
either into ergosterol-containing or ergosterol-free vesicles
point to a direct interaction of the protein with ergosterol
[39].
A crucial role of phosphatidyl ethanolamine (PE) in
membrane processes of both eukaryotic and prokaryotic
cells has recently been documented. Due to its headgroup,
which is relatively small compared to the bulky acyl chains,
PE has a tendency to form nonbilayer structures. This
property determines PE localization in close vicinity of
membrane proteins (it often copurifies with a protein) where
it stabilizes the protein and compensates for a putative
disturbance of the bilayer caused by polytopic protein
insertion [53]. It was found to be indispensable or stimula-
tory for activities of a number of membrane proteins (Table
1). As early as 1984, a strict requirement for PE was reported
for membrane potential-driven uptake of lactose by lactose
permease (LacY) [25,54]. An energy-independent counter-
flow mediated by LacY showed a broad tolerance for various
phospholipids. Using E. coli mutants lacking PE, Bogdanov
et al. have documented in a series of excellent studies a novel
and very specific role of PE. A combination of in vitro and in
vivo studies has established the function of PE as a molec-
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Table 1
Membrane proteins affected in their activities by specific lipids and/or sterols
Membrane protein Lipid Effect Reference
P-glycoprotein PC, PE Restore activity of delipidated ATPase [1]
Headgroup and acyl chains affect drug binding affinity
Cholesterol Increases ATPase activity; alters Pgp function [3]
Ca2 + ATPase PI-4 phosphate 2- to 4-fold increase in ATPase activity [4,5]
PE Stimulates catalytic activity [6]
Cholesterol Specific binding sites at the lipid–protein interface [7]
Na+/K+-ATPase Cholesterol Increases maximum specific activity [8]
g-Aminobutyric acid transporter Cholesterol 20-fold stimulation of activity [9]
L-Glutamic acid transporter Cholesterol 5-fold stimulation of activity [9]
Serotonin transporter Cholesterol Requirement for citalopram binding [10]
Nicotinic acetylcholine receptor—AcChR Cholesterol Alters gating function via changes in the
secondary structure
[11]
Rhodopsin Cholesterol Stabilization of the molecule [12]
Oxytocin receptor Cholesterol Stringent requirement for the high-affinity
receptor state
[13–15]
Galanin receptor GalR2 Cholesterol Specific requirement for ligand binding [16]
Human adenosine A2a receptor Cholesteryl
hemisuccinate
Cholesteryl hemisuccinate increases receptor
stability in detergent
[17]
Phosphate carrier CL 30-fold increase of specific activity [18,19]
Mitochondria
Cytochrome c oxidase see Table 2 2 CL per monomer required for activity [19,20]
Mitochondria
Pyruvate carrier CL Requirement for activity and stability [19,21]
Mitochondria
ADP/ATP carrier CL Strong effect on conformational transition and [19,22]
Mitochondria ADP binding
mammals
Mitochondria Strong stimulation of activity in a mutant with reduced [23]
S. cerevisiae protein-associated CL
Metabotropic glutamate receptor
(DmGluRA)
Ergosterol Glutamate binding by DmGluRA overexpressed in
photoreceptor cells is strictly dependent on the
[24]
D. melanogaster presence of ergosterol
Lac permease PE Required for H+-coupled transport, not for [25–28]
E. coli energy-independent translocation
Acts as a molecular chaperone for correct folding
and membrane topology
[29]
ABC-transporter OpuA PG/PS Osmotic stress sensed via alterations in ionic [30]
L. lactis interaction with lipids
Pore protein PhoE PE Required for trimerization of PhoE in vitro [31]
E. coli
SecYEG translocase PG Essential for preprotein translocation [32,33]
E. coli; B. subtilis PE Stimulatory in E. coli; essential in B. subtilis
(continued on next page)
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ular chaperone directing the proper assembly of the perme-
ase in the membrane bilayer [55]. The same authors showed
that the critical folding steps occur after LacY membrane
insertion [27]. In the most recent study, they demonstrated
that the topology of the permease in the membrane can be
changed in a reversible manner in response to the presence
or absence of PE. Thus, the N-terminal half adopts an
inverted topology in PE-less cells; domains normally non-
translocated are translocated and vice versa [29].
In S. cerevisiae, an essential role of PE that is independ-
ent of its ability to form nonbilayer structures, has recently
been demonstrated in the function of mitochondria-related
processes [56,57]. PE in yeast can arise via three independ-
ent pathways. Hence, for obtaining a mutant completely
depleted of PE, three genes have to be disrupted (PSD1,
PSD2, DPL1). The triple mutant can grow only in the
presence of ethanolamine [58]. Its specific requirement for
PE could not be satisfied by phosphatidyl propanolamine—
a structurally related lipid capable, as PE, of forming the
hexagonal phase [57].
When ethanolamine in the medium is replaced by chol-
ine, growth of the yeast triple mutant (psd1D, psd2D, dpl1D)
ceased after two or three generations. For a limited time
period, however, the choline-grown cells retain the same
viability as those grown on ethanolamine. This fact made it
possible to identify a specific effect of PE on transport
processes coupled to the proton motive force [40]. In the
case of the arginine permease Can1p, it was shown that
severe PE depletion of the cells affects primarily the
delivery of the permease through the secretory pathway to
the plasma membrane [41]. This may very well be due to a
wrong membrane topology as described for the lac perme-
ase of E. coli [29].
3. Lipids as components of membrane protein complexes
For most of the examples given in Table 1, the evidence
that individual lipid species exert a specific effect on a
membrane protein is not really compelling. Indirect effects
like changes in fluidity may still, at least in part, be involved
in the phenomena described. Large bulk effects, especially
due to cholesterol content, on the physical state of the
phospholipid bilayer have been well documented. It is
Table 1 (continued)
Membrane protein Lipid Effect Reference
Hyaluronan synthase CL Pore formation together with the protein postulated [34]
Streptococcus
Monoglucosyl-diacylglycerol synthase PG, CL Strong activation [35]
A. laidlawii
Chitin synthase PS Required for activity in vitro [36]
S. cerevisiae
Plasma membrane ATPase PI, PG Required for activity in reconstituted system [37]
S. cerevisiae
Pdr5 Ergosterol erg mutants have a reduced Pdr5 efflux activity [38]
S. cerevisiae
Arginine permease Can1p Ergosterol Ergosterol–nystatin interaction uncouples the
permease from proton motive force
[39]
S. cerevisiae PE depletion in
whole cells
Strong effect on Can1p activity and several other
protonmotive force-driven permeases
[40]
Affects targeting to the plasma membrane [41]
Tryptophan permease PS depletion in
whole cells
Strong effect on tryptophan uptake [42]
S. cerevisiae Ergosterol Low tryptophan transport in Erg6 disruptant [43]
Glucose/H+ symporter Hup1p Ergosterol Stimulation of protein expressed in E. coli and
reconstituted in vitro
[44]
Chlorella PC Stringent requirement for protein stabilization
during solubilization
[45]
H+-ATPase Corn roots Sterols H+ pumping selectively stimulated by cholesterol
and stigmasterol
[46]
Photosystem II Spinach PG Involved in dimer–monomer interconversions [47]
Synechocystis Essential for photosynthetic activity in vivo [48]
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generally not easy to distinguish unambiguously bulk
effects from specific ones. Even within related groups of
membrane proteins, like the seven-transmembrane-helix G
protein-coupled receptors (GPCRs), the activities of indi-
vidual receptors exhibit different types of dependency on
cholesterol. For example, the cholecystokinin receptor
responds to fluidity effects caused by cholesterol, whereas
the activity of the oxytocin receptor is affected mainly by
highly specific interactions with cholesterol [14].
The strongest evidence for highly specific protein–phos-
pholipid and/or sterol interactions comes from 3D structures
of membrane proteins. Examples are briefly summarized in
Table 2.
A specific CL requirement for the activity of cytochrome
c oxidase has been studied since the 1970s [70]. Of 14
phospholipid molecules associated with bovine cytochrome
c oxidase crystals, three are CL [59]. Whether all three have
to be present and what their exact function is, can now—
after 30 years—be asked. The question can possibly be
answered with the employment of site-directed mutagenesis
leading to the loss of binding of individual CL molecules.
The electron density resolution of crystals of cytochrome c
oxidase from Paracoccus denitrificans achieved so far
allowed the modeling of one phosphatidyl choline (PC)
molecule in subunit III. The lipid forms two ion pairs via its
phosphate and its quaternary ammonium [61].
The most detailed analysis of a membrane protein con-
cerning its lipid content has been reported for the cytochrome
bc1 complex (ubiquinol:cytochrome c oxidoreductase,
QCR) from yeast [62]. Five phospholipid molecules asso-
ciated with the protein were identified. Amino acids inter-
acting with phosphatidyl inositol (PI) and CL were changed
by site-directed mutagenesis. The phosphodiester of PI
interacts with Lys272. The mutant K272A is active in vivo,
but shows only 1% of the activity when tested in vitro. This
is due to the loss of one of the three essential subunits of the
multisubunit protein complex, the Rieske subunit. It is
concluded, therefore, that PI stabilizes this subunit within
the complex. No stable complex at all could be isolated when
the three lysyl residues interacting with CL were exchanged.
Table 2
Lipids as components of crystallized membrane proteins
Protein Lipids Remarks Function Reference
Cytochrome c oxidase 3 PE, 7 PG, 1 PC, 3 CL 5 molecules at the outer leaflet
of the inner mitochondrial
membrane, 9 at the matrix side
CL essential for activity [59,60]
Bovine
Cytochrome c oxidase 1 PC Forms two ion pairs with Arg233
and Asp74 of subunit III
[61]
Paracoccus denitrificans
Cytochrome bc1 2 PEa, 1 PIa, 1 PCa, 1 CLa 1 PE interacts with both monomers Dimer stabilisation [62]
Saccharomyces cerevisiae PI is in interhelical position Stabilizes complex via
interaction with Lys272
All lipids except PI are on the matrix
side of the mitochondrial membrane
One of the CL phosphodiesters
may be part of the proton
translocation path
Photosystem I 3 PG, 1 MGD All located at the stromal side of the
membrane
[63]
Synechococcus elongatus
Phosphodiester of one PG binds one
antenna chorophyll a
Reaction center 1 CL One phosphodiester of CL interacts
with His145 and Arg267 of subunit M
[64]
Rhodobacter sphaeroides
K+ channel KcsA 2 PG [65]
Streptomyces lividans
Bacteriorhodopsin 6 dietherlipids/trimer
[sulfated triglyceride
lipid (S-TGA-1)]
Stabilization of BR-trimer [66]
Halobacterium salinarum
1 squalene and 5
PGP/monomer
1 squalene and 1 PGP essential for
normal photocycle characteristics
[67]
18 phytanyl lipids/trimer Form annulus around trimer [68,69]
In part fill grooves of the proteins
a Per monomer.
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In addition to the stabilizing function of lipids, the authors
suggest that one of the phosphodiester groups of CL and the
phosphodiester of PE might take part in proton conduction
leading to the reduction of ubiquinone.
A specific interaction of CL with an integral membrane
protein has been documented also for the reaction center of
the photosynthetic bacterium Rhodobacter sphaeroides
[64]: one phosphodiester group interacts with two basic
amino acids of subunit M. An exchange of the correspond-
ing amino acids has not been published so far. A resolution
of 2.5 A˚ of another crystallized photosynthetic reaction
center, Photosystem I of the cyanobacterium Synechococcus
elongatus, allowed the detection of three molecules of PG
and one monogalactosyl diglyceride within subunit PsaA/
PsaB [63]. Functional analysis of the lipids has not been
carried out. The same holds for two molecules of PG present
in the K+-channel (KcsA) of the bacterium Streptomyces
lividans (Ref. [65] and pers. comm.).
Lipid components of the bacteriorhodopsin complex have
been analysed in detail [66–69]. Two glycolipid sulfates, five
phosphatidyl glycerophosphates (PGPs), one-half PG and
one-half phosphatidyl glycerosulfate (PGS) (all containing
phytanyl chains) accrue to one monomer. One PG as well as a
squalene are essential for activity and are most likely required
for reprotonation of retinal via Asp96 [67]. Several lipid
molecules exactly fill corresponding grooves in the protein
‘‘displaying a surprising extent of structural complementar-
ity’’ [68].
To fully understand the importance of various lipids
comprised within membrane protein complexes, directed
mutagenesis is used for exchanging the amino acids respon-
sible for the lipid/protein interactions. Three-dimensional
structures of the proteins are required to identify these
amino acids, and therefore large quantities of purified active
proteins have to be available. The activity and stability of
these proteins, however, depend on specific lipids. This in
turn has to be considered, especially if heterologous expres-
sion systems are used for protein overproduction (see
below).
4. Lipid composition of different organisms
Among the various phospholipids, PC is generally con-
sidered a bilayer-forming lipid and is found in the majority
of membranes. Every biological membrane has at least one
nonbilayer-forming lipid component. Under physiological
conditions, it is represented by PE and/or monogalactosyl/
monoglucosyl diacylglycerol. The latter neutral lipids are
found in high concentrations in chloroplasts, Gram-positive
bacteria that lack PE [71] and in organisms like Achole-
plasma laidlawii [35]. Negative charge is brought to the
membrane by anionic lipids phosphatidyl serine (PS), PG,
CL and phosphatidic acids (PA). While PS represents the
major anionic lipid in plasma membranes of eukaryotes, PG
and CL fulfill this function in prokaryotes and mitochon-
drial membranes. CL and PA can form nonbilayer structures
in the presence of special divalent cations.
Organisms have a tendency to maintain the physicochem-
ical properties of their membranes within defined limits.
Even simple prokaryotic cells regulate their lipid composi-
tion to be optimal in response to environmental conditions.
For instance, to maintain a proper balance between bilayer
and nonbilayer lipids, the acyl chain composition of the lipid
envelope of E. coli varies with growth temperature [72].
All eukaryotic cells are characterized by the presence of a
large number of membrane-bounded organelles. The plasma
membrane typically contains sterols and sphingolipids
which are lacking in prokaryotic and in subcellular mem-
branes. The subcellular membranes of eukaryotes resemble
those of prokaryotes.
The lipid composition of membranes is not constant. In
the simple eukaryotic cell of S. cerevisiae, the ratios of
individual phospholipids differ not only among the different
wild-type strains, but they also change depending on the
carbon source and cultivation conditions [73]. The major
sterol in yeast is represented by ergosterol. Sphingolipids in
this organism are characterized by their inositol moiety and
are located primarily in the plasma membrane where they
account for 7–8% of the total mass of the membrane (30%
of the plasma membrane phospholipids) [74].
Like in yeast, ergosterol is also the main sterol of
Drosophila, when the flies are fed with a diet containing
yeast [82].
In mammalian cells, the major sterol is cholesterol. Its
cellular levels are highly regulated. To maintain the optimal
concentration of cholesterol in the cell, its distribution is
regulated between the different membranes. Sphingolipids,
particularly sphingomyelin and glycosphingolipids, have
been well established as essential components of mamma-
lian cells, where they are predominantly found in the outer
leaflet of the plasma membrane [91]. There is a selective
confinement of cholesterol, sphingolipids and certain pro-
teins in discrete regions of the membrane. These domains,
named lipid rafts, appear to be an ubiquitous feature of
mammalian cells [92]. Lipid rafts are likely to contribute to
the structure and function of caveolae, plasma membrane
invaginations, that are implicated in membrane traffic and
signaling events. Similar domains were also described in
yeast where they function in biosynthetic delivery of pro-
teins to plasma membrane [93]. Generally, membrane pro-
teins requiring high concentrations of cholesterol are located
exclusively in rafts.
The lipid composition of plasma membranes of cultured
cell lines (e.g. BHK cell) is usually similar to that found in
plasma membranes of mammalian cells in general. Sphin-
gomyelin, sphingolipids and free cholesterol are enriched in
this membrane type. Lysosomal membranes in BHK cells
contain a large amount of lysobiphosphatidic acid (LBPA)
and the phospholipids characteristic for mammalian cells.
LBPA is enriched in cultured BHK, human liver and rabbit
alveolar macrophages [88].
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5. Heterologous expression of membrane proteins
Excellent reviews about heterologous expression of
membrane proteins have been published [94–98] and
altogether, a myriad of papers concerning individual mem-
brane proteins and membrane protein complexes have
appeared, which obviously cannot be the topic of this
review. A very detailed and critical analysis of the over-
expression problems met with the serotonin transporter has
been written by Tate [99]; a large number of different
expression systems have been compared. In the following,
we therefore have picked only a few examples of heterol-
ogous membrane protein expression, where problems of
specific lipid requirement have been noticed or should at
least be thought of.
5.1. Prokaryotes as hosts
As summarized in Table 1, for 10 mammalian membrane
proteins, positive effects were shown to be caused by the
presence of cholesterol. Expression of these proteins in
bacteria, therefore, would be expected not to yield fully
functional proteins. Successful expression of the majority of
fully functional GPCR proteins has been achieved in E. coli,
however, indicating that cholesterol is unimportant for the
function of these particular receptors. For reconstitution of
E. coli expressed receptors, however, it has been shown that
the presence of cholesteryl hemisuccinate during the solubi-
lization and purification steps was required. Only then a
100% functional neurotensin receptor from rat [100] and an
adenosine A2a receptor from human [17] was obtained in
good yield. These examples point to a non-specific bulk
effect of sterols required for stabilization of the receptor
molecules in their native conformation before they are
embedded in a lipid bilayer. Also for the olfactory receptor
expressed in bacteria, cholesterol was not essential for
activity [101].
The failure to express functional serotonin transporter in
E. coli is thought to be due to the lack of cholesterol [99].
On the other hand, mouse mdr1 protein has been function-
ally expressed in E. coli [102], although it has been shown
that in vitro mammalian Pgp does require PC and choles-
terol for its optimal activity [1,3]. Because E. coli lacks both
these membrane components (Table 3), this discrepancy
could be due to the fact that generally qualitative but rarely
quantitative comparisons (specific activities) are made
[102]. Another possible explanation could be that the
positive effects of cholesterol and PC on Pgp activity
observed in vitro may not be observable to the same extent
in vivo. Other phospholipids of E. coli might replace, at
least partially, the eukaryotic lipid components in vivo.
A plant protein—the Chlorella hexose/proton symporter
(HUP1 gene product)—with 12 transmembrane helices, has
also been functionally expressed in E. coli [44]. The
activity of the solubilized and reconstituted protein was
stimulated in the presence of ergosterol. However, the
activity of the same transporter expressed in and solubilized
from Schizosaccharomyces pombe (which contains ergo-
sterol) showed a five-fold higher in vitro activity than that
expressed in E. coli and reconstituted in the presence of
ergosterol. Later it was found that the HUP1 protein
obligatorily requires PC for stabilization [45]. The low
activity of the protein produced in E. coli might be due
to the lack of PC during the preparation. Again, it is not
sure to what extent the HUP1 protein requires PC and
sterols in vivo. However, the finding that the transporter
expressed in yeast and purified to homogeneity contains
one to three molecules each of ergosterol, PC and PE per
HUP1 molecule, certainly is in line with the positive effects
of these components on the transporter activity [44,45]. The
in vivo PE requirement of a number of H+-symporters [41]
has been discussed above.
A promising study with the aim to yield large amounts of
heterologously expressed membrane proteins was started by
Turner et al. [103]. It was initiated by the observation that
up to 30 mg of bacteriorhodopsin can be obtained per liter
of Halobacterium salinarum culture, and by the idea that
similar amounts of various heterologous membrane proteins
might be obtained by overexpression in H. salinarum. From
three receptors tested, only the Ste 2 pheromone receptor
from yeast was found in the membrane fraction while two
human GPCRs could not be detected [103]. Whether this
was solely a transcriptional problem or whether the choles-
terol requirement shown for some of GPCRs (see Table 1)
caused an additional problem remains an open question.
Certainly, the unusual lipid composition of the archaea is
expected to aggravate the situation whenever specific lipid
components are required for proper function of heterolo-
gously expressed proteins.
It has been stated that for overexpression of proteins, it
‘‘generally does not matter in which particular cellular
membrane they are located, as long as they are correctly
folded and are processed to their active form’’ [94]. But can,
for example, cytochrome bc1 requiring CL (Table 2), be
correctly folded in a membrane lacking this phospholipid?
In this context, it is of interest that E. coli mutants were
selected that proliferated a large amount of internal mem-
branes when overproducing subunit b of F1F0 ATP synthase
[104]. The lipid composition of these intracellular mem-
branes differs from those of the cytoplasmic membrane;
they are enriched in CL and contain almost half of the
normal amount of PG. [104].
5.2. Insect cells as hosts
Insect cell lines contain a rather low quantity of choles-
terol and no PS in their plasma membrane, whereas the PI
content is comparatively high [81]. The very low content of
sterols as compared to phospholipids (a ratio of 0.04; for
mammalian and yeast plasma membranes, it is > 0.5; see
Table 3) could potentially be a bottleneck for the over-
expression of sterol-requiring membrane proteins. Indeed,
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Table 3
Lipid composition of biological membranes
Organism Lipid Reference
PROKARYOTES
Escherichia coli Inner membrane: [2,75]
Gram-negative PE 70–80%; PG 15–20%; CL 5%
Bacillus megaterium PE—35%, PG—48%, CL—11%, glucosoaminyl PG—6% [75,76]
Gram positive
Archaea:
Halobacterium Analogs of archaeol ( = diphytanylglycerolether): PG, PGP, PGS,
PA, methyl-PGP (main phospholipid); S-TGA1 and other glycolipids
[71,77]
Thermoacidophilesa Analogs of caldarchaeol ( = dibiphytanyldiglycerol tetraether) with
inositol phosphate and various saccharides, respectively, attached;
other glyco- and phosphoglycolipids
EUKARYOTES
Yeasts
Saccharomyces cerevisiaeb Percentage of plasma membrane PL
Plasma membrane PC 17%; PE 20%; PI 18%; PS 34%; PA 4%; CL 0.2% [74,78,79]
(Sphingolipidsf 30%)
Ergosterol/PL (mol/mol)f 0.9
Mitochondria Percentage of mitochondrial PL
PC 40%; PE 26%; PI 15%; PS 3%; PA 2%; CL 13% [78]
Ergosterol/PL (mol/mol) 0.2
Pichia pastorisb Percentage of total lipids
Whole cell extract PL 48%; ceramides 2%; sterol (free) 31%; sterol derivatives 16% [80]
Percentage of total PL recovered from whole cells
PC 38%; PS 28%; PE 18%; PI 11%; PA 3%; CL 2%
Insect cell lines
Spodoptera frugiperda Sf9 Percentage of total phospholipid recovered from whole cells [81]
PC 35 (43)%; PI 23 (17)%, PE 36 (36)%; CL 4.6 (4.7)%
(Trichoplusia ni) PS, glyco- and sphingolipids—not detected
Whole cell extract Cholesterol/PL (mol/mol) 0.04
Drosophila melanogasterc PC, PE, PS, PI—not quantified [82]
Embryonic membranes Glycosphingolipids: two ceramides—not quantified
Sterols: ergosterol 69%, cholesterol + dehydrocholesterol 14%,
campesterol+ sitosterol 9%, others 8%
Xenopus oocytes Percentage of total PL recovered from whole cells [83,84]
PE 19%; PC 65%; PI 10%; PS 2%; sphingomyelin 5%
Cholesterol/PL (mol/mol) 0.6–0.7
Plants
Plasma membrane (oat coleoptile and root) Percentage of total lipids [85–87]
Phospholipids 42–50%
PA 11–15%; PE 9–15%; PC 9–14%; PS 3–4%; PI 2%; PG 1–2%
Glycolipids 25–39%d
sterylglycoside 13–15%; glycerocerebroside 10–26%d
Sterols (free) 19–25%e
sitosterol 5–9%; campesterol 2%; stigmasterol 2–12%e
others 4–8%
Choloroplasts Percentage of total chloroplast lipids
Galactolipids 60–70%
monogalactosyldiglycerides 40–50%
digalactosyldiglycerides 15–25%
Sulfolipids 1–5%
Phospholipids 16%
mainly PG
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an addition of cholesterol to the medium of infected Sf9
insect cells positively affected the properties of the hetero-
logously expressed mammalian oxytocin receptor [105].
The number of the high-affinity receptor binding sites
increased by a factor of 3. The low cholesterol level in
Sf9 may be the cause of the low activity of the GPCRs
expressed in this insect cell line [106]. However, the same
low level of cholesterol is obviously sufficient for express-
ing functional Na+/K+-ATPase [107].
An interesting alternative to the conventional baculovirus
expression system has been reported recently [24]. Photo-
receptor cells of transgenic Drosophila melanogaster were
used for an expression of GPCRs. Two homologous proteins
were obtained in high yield. The expression level of the
human vasopressin 1A receptor (V1A) was claimed to be
better than when expressed in E. coli and Sf9 cells [24]. A
homologous receptor expressed in photoreceptor cells
requires obligatorily ergosterol, which indeed is present in
D. melanogaster reared on yeast-based diet (see Tables 1
and 3) [82].
5.3. Yeast cells as hosts
The yeasts S. cerevisiae, S. pombe and Pichia pastoris
have frequently been used as host organisms for heterolo-
gous expression, mainly also because, in contrast to mam-
malian or insect cell lines, these eukaryotic cells can be
grown in large amounts in inexpensive media [94]. S.
cerevisiae has also been used to identify a large number of
membrane transport proteins from plants by complementing
defects in the uptake of specific substrates [96,108]. Com-
plementation studies, however, often do not reflect quanti-
tative aspects of functional expression and thus successful
complementation is no evidence that the corresponding
proteins are optimally furnished with their required lipids.
The bottleneck in the expression could again be due to a
shortage of cholesterol in the case of mammalian membrane
proteins, and of specific sterols (sito-, stigma- and campes-
terol) in the case of plant proteins. The main fungal sterol,
ergosterol (a 24 methyl, 7, 8/22, 23 dehydro cholesterol)
might replace the plant and animal sterols, but this often
does not result in fully functional heterologous proteins.
Human MDR1 expressed in S. cerevisiae showed greatly
decreased drug binding as compared to that of the authentic
protein. It was found that, indeed, ergosterol inhibits azi-
dopine binding [109]. On the other hand, in other studies,
no significant differences between MDR proteins expressed
in S. cerevisiae and mammalian cells were observed
[110,111]. However, it has also been documented that
MDR1 protein expressed in S. pombe [112] although
reacting with peptide substrates (valinomycin and actino-
mycin D) did not accept adriamycin, which normally is one
of its substrates, too. This may indicate that the ‘‘correct’’
membrane environment (cholesterol?) influences the sub-
strate specificity of this protein. Ergosterol also is not able
to compensate for the cholesterol requirement of the sero-
tonin transporter [99].
The multidrug resistance-associated protein (MRP1)
transporting glutathione, glucuronide, and sulfate-conju-
gated organic anions out of cells, was overexpressed in P.
pastoris [113] at a level 30-fold higher than in HeLa/MRP1
transfectants. No functional difference between the two
heterologous proteins was observed [110]. No specific lipid
requirements have so far been reported for this transporter
subgroup of the ABC family.
Cholesterol was shown to accelerate the phosphorylation/
dephosphorylation reaction of the Na+/K+-ATPase in vitro
(Table 1). However, the enzyme was also functionally
expressed in S. cerevisiae [114,115] indicating thus that
cholesterol might have been replaced by ergosterol.
The properties of two human GPCR proteins, the A-
opioid receptor and the D2S dopamine receptor, were shown
to be influenced by membrane components. The ligand
binding to A-opioid receptor was increased in yeast mem-
branes when ergosterol was removed and replaced by
cholesterol [116]. Ligand binding affinity of the dopamine
receptor expressed in yeast differed significantly from the
affinity of the receptor embedded in its natural environment.
Moreover, the receptor affinities were different when the
proteins were expressed in S. pombe and S. cerevisiae and
compared to each other [117]. The component responsible
for these differences has not been identified.
To date, only a few plant membrane proteins heterolo-
gously expressed in S. pombe and in S. cerevisiae have been
Table 3 (continued)
Organism Lipid Reference
Mammalian cells
BHK21 cell line Percentage of plasma membrane phospholipids [88,89]
Plasma membrane PE 29%; PC 26%; sphingomyelin 24%; PS 18%; PI 3%
Cholesterol/PL (mol/mol)f 0.9
Rat hepatocytes PC 32–47%; PE 14–20%; sphingomyelin 13–24%; PS 4–8%,
PI 7–10%; cerebrosides 1–3%; PA 2–3%
[90]
Plasma membrane Cholesterol/PL (mol/mol) 0.6–0.7
a Surprisingly, some of the most extreme thermophiles possess lipids exclusively of the archaeol type [77].
b Cells grown on glucose.
c Reared on yeast-based medium.
d Low value for roots.
e High value for roots.
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purified and studied in vitro [118–121]. Quantitative com-
parative studies of the heterologous proteins with the
proteins in their native membranes are almost completely
missing. The substrate spectrum and kinetic parameters for
the Chlorella HUP1 protein expressed in S. pombe were
found to be identical with that from Chlorella [122]. The Km
values for ATP hydrolysis, as well as the specific molecular
activity of the heterologous plant H+-ATPase purified from
S. cerevisiae agree with the data reported for ATPase
obtained from the native membrane [121]. These observa-
tions indicate that ergosterol can, to a large extent, replace
the specific plant sterols.
Finally, it should be mentioned that the first successful
heterologous expression of a membrane protein in yeast
(bacterio opsin from H. salinarum) was achieved by Hilde-
brandt et al. [123]. Today, we know about the specific lipid
components visualized within the bacteriorhodopsin crystals
(Table 2). These lipid components are not present in yeast
and it is therefore surprising that the authors obtained
immunopositive material at all and achieved an incorpora-
tion of retinal supplied to the medium.
6. Conclusion and summary
Biologically active membrane proteins frequently occur
as protein–lipid complexes. We gathered here 30 examples
of membrane proteins from prokaryotes, yeast, plants and
mammals, in which specific phospholipids and sterols were
shown to be important for optimal activities. Although bulk
effects of lipid components can rarely be fully excluded, the
collective evidence clearly supports the essential role of
specific phospholipid headgroups and/or specific structural
features of sterols in functional protein–lipid interactions.
Direct evidence for defined lipid–protein contacts is
corroborated by six crystallized membrane protein com-
plexes discussed in this survey. A definition of the actual
function of the associated lipid molecules will require
studies involving an exchange of the interacting amino
acids by site-directed mutagenesis. For the yeast cyto-
chrome bc1 complex, this has partly been conducted; the
amino acid changes resulted in pronounced instabilities of
the protein complex (demonstrated mainly in vitro) [62].
In addition to their stabilization function, specific phos-
pholipids were shown to be required for the correct orienta-
tion of certain transmembrane helices within the membrane
[29] or for correct transport through the secretory pathway
[41]. These lipids may play a transitory role, therefore, and
may not be necessary for the function of the final product.
Heterologous expression of membrane proteins is usually
designed with the aim to obtain large amounts of the fully
active protein of interest. With respect to the specific lipid
requirements of membrane proteins, it is desirable that the
phospho- and glycolipid, as well as the sterol content of the
host cell chosen for the heterologous expression, are care-
fully considered. The lipid composition of bacteria, archaea,
yeasts, insects, Xenopus oocytes, typical plant and mamma-
lian cells are given in Table 3 of this review.
Problems in heterologous expression of membrane pro-
teins due to different lipid environments within host cells
have been observed at times. Often they may have escaped
notice and may have been comprised under ‘‘inefficient
expression system’’. Finally, it should be pointed out that
the presence of specific lipid components during crystalli-
sation trials may be of crucial importance [124].
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